I am a British Heart Foundation Centre of Research Excellence Fellow and Assistant Supervisor with the Cardiovascular Genomics group at the National Heart and Lung Institute. With my background in metabolomics and common variant analyses, and my current work in rare variant analyses and large data sets (e.g. phenotyping and imaging), I investigate the role of genetic factors in cardiomyopathy risk by analysing the whole exome sequencing data of 200,000 volunteers from the UK Biobank, and patient cohorts.
After my undergraduate degree in Natural Sciences with a 2-year moderatorship in Genetics at Trinity College Dublin, Ireland, I undertook a 4-year Ph.D. in Cardiovascular Sciences, funded by the Medical Research Council, UK, entitled “Heritability and family-based GWAS analyses to discover novel lipidomic biomarkers of Cardiovascular Disease” with Prof. Bernard Keavney and Prof. Anna Nicolaou at the University of Manchester. I was afforded 'time out of programme' research experiences with the University of Cape Town, South Africa under Prof. Bongani Mayosi, and with Stoller Biomarker Discovery Center, Manchester, UK under Prof. Anthony Whetton. I continue to lecture with the University of Manchester in pharmacogenetics as an Honorary Lecturer for the Division of Pharmacy and Optometry. For my first year of postdoctoral work, I was at the intersection of rare variant analysis with Dr. James Ware and deep imaging data analyses with Prof. Declan O'Regan at the National Heart and Lung Institute, Imperial College London, UK.
Outcomes and phenotypic expression of rare variants in hypertrophic cardiomyopathy genes amongst UK Biobank participants.
de Marvao A., McGurk K., et al., (pre-print) 2021, medRxiv.
Genetic and environmental determinants of diastolic heart function.
Thanaj M., Meikle J., McGurk K., et al., (pre-print) 2021, medRxiv.
Circulating ceramides as biomarkers of cardiovascular disease: evidence from phenotypic and genomic studies.
McGurk K., et al., (accepted) 2021, Atherosclerosis.
Heritability and family-based GWAS analyses of the N-acyl ethanolamine and ceramide plasma lipidome.
McGurk K., et al., March 2021, Human Molecular Genetics.
The genetic architecture of left ventricular non-compaction reveals both substantial overlap with other cardiomyopathies and a distinct aetiology in a subset of cases. Mazzarotto, F., Hawley, M., Beltrami, M., Beekman, L., de Marvao, A., McGurk, K., et al., Jan 2021, Genomics in Medicine.
Heritability of haemodynamics in the ascending aorta.
McGurk K., et al., Sept 2020, Scientific Reports.
The use of missing values in proteomic data-independent acquisition mass spectrometry to enable disease activity discrimination.
McGurk, K., et al., Apr 2020, Bioinformatics.
The Open Science of Atrial Fibrillation.
Keavney, B. & McGurk, K., Jan 2020, Circulation research. 126, p. 210-211
Marked variation in heritability estimates of left ventricular mass depending on modality of measurement.
Nethononda, R., McGurk, K., et al., Sep 2019, Scientific Reports.
2020: Ph.D. in Cardiovascular Sciences, University of Manchester, UK.
2016: “Design and Analysis of Genetic-Based Association Studies” at the Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
2016: “Introduction to R” at the MRC Biostatistics Unit, Cambridge, UK.
2015: BA. Hons. in Natural Sciences with a Moderatorship in Genetics, Trinity College Dublin, Ireland.
2011: Leaving Certificate, Wesley College Dublin, Ireland. Chemistry (A*) Biology (A).